Otofarma SpAMIL:OTO -0.71%16 Days Payable is 317.41 as of Dec. 2024, which is 5% above its 10-year median of 301.07. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 795 Medical Devices & Instruments companies, Otofarma SpA ranks better than 89.31% on this metric.
The historical rank and industry rank for Otofarma SpA's Days Payable or its related term are showing as below:
MIL:OTO'
s Days Payable Range Over the Past 10 Years
Min: 284.72 Med: 301.07 Max: 317.41
Current: 317.41
During the past 2 years, Otofarma SpA's highest Days Payable was 317.41. The lowest was 284.72. And the median was 301.07.
MIL:OTO's Days Payable is ranked better than 89.31% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs MIL:OTO: 317.41
Otofarma SpA's Days Payable
increased
from . 20 (0.00) to Dec. 2024 (317.41).
It may suggest that Otofarma SpAdelayed paying its suppliers.
Otofarma SpA Days Payable Related Terms
Otofarma SpA Days Payable Historical Data
* Premium members only.
The historical data trend for Otofarma SpA's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA Days Payable Chart
Otofarma SpA Annual Data
Trend
Dec23
Dec24
Days Payable
284.72
317.41
Otofarma SpA Semi-Annual Data
Dec23
Dec24
Days Payable
284.72
317.41
MIL:OTO vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Otofarma SpA's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Otofarma SpA Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Otofarma SpA's Days Payable distribution charts can be found below:
* The bar in red indicates where Otofarma SpA's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Otofarma SpA's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Otofarma SpA (MIL:OTO) has a Days Payable of 317.41 as of Dec. 2024. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Otofarma SpA and its competitors. This is near median its historical median of 301.07. Over the past decade, Otofarma SpA's Days Payable has ranged from 284.72 to 317.41. According to the industry distribution chart, Otofarma SpA ranks #85 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 10.7%.
Is Otofarma SpA's Days Payable too high?
Otofarma SpA's current Days Payable of 317.41 is near median its 10-year median of 301.07. Over the past 10 years, this metric has ranged from a low of 284.72 to a high of 317.41. The Medical Devices & Instruments industry median Days Payable is 68.07. Otofarma SpA's value of 317.41 is 366.3% above this industry median. Based on the distribution chart, Otofarma SpA ranks #85 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Otofarma SpA ranks #85 out of 795 companies for Days Payable. This places Otofarma SpA in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Otofarma SpA's value of 317.41 is 366.3% above this benchmark. Historically, Otofarma SpA's own Days Payable has ranged from 284.72 to 317.41 over the past decade. While the company's 10-year median is 301.07 vs. the industry median of 68.07, Otofarma SpA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Otofarma SpA's current Days Payable of 317.41 is 366.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Otofarma SpA and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Otofarma SpA's current Days Payable is 317.41, which is near median its own 10-year median of 301.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Days Payable of 317.41. The current Days Payable is 317.41, which is near median its 10-year median of 301.07 and 366.3% above the Medical Devices & Instruments industry median of 68.07. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Days Payable is 317.41 as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score
Get the complete analysis for MIL:OTO
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:OTO has been successfully added to your 